MDisrupt, a Texas-based healthcare technology marketplace, secured a $1 million investment from American Heart Association Ventures. This funding, milestone-based with a portion tied to a beta launch, supports MDisrupt’s AI-powered platform designed to connect medtech innovators with healthcare experts. The investment reflects AHA’s commitment to advancing evidence-based health solutions.
In addition to the investment, MDisrupt and AHA entered into a collaboration to co-develop a platform that enables healthcare innovators to access expert advice. With AI-powered matchmaking, the platform will streamline connections between life sciences companies and seasoned professionals, fostering the development of clinically valid and impactful healthcare products.
The platform will tap into AHA’s extensive network of clinicians, scientists, and researchers, enabling the dissemination of evidence-based science into healthcare innovation. Both companies anticipate releasing the new offering, featuring AHA experts, by mid-2025. This partnership is expected to drive the next generation of evidence-based healthcare and medtech products, accelerating their market readiness.
Click here to read the original news story.